Table 4.
Eventa | Study Phase | Duration, Days | Outcome | Maximum Toxicity Grade |
---|---|---|---|---|
Abnormal brain MRI | pre-treatment | NR | NR | NR |
Abnormal tympanometry | pre-treatment | NR | NR | NR |
Alteration in periventricular white matter on brain MRI | pre-treatment | 1,121 | resolved | NR |
Broad-based walking | pre-treatment | ongoing | not resolved | NR |
Enlarged lateral ventricular on brain MRI | pre-treatment | NR | NR | NR |
Low-amplitude EEG waves with poor organization | pre-treatment | ongoing | not resolved | NR |
Psychomotor hyperactivity | pre-treatment | ∼2 years | resolved | NR |
Sensory neural hearing loss (bilateral) | pre-treatment | ongoing | not resolved | NR |
Hypotonia | pre-treatment | 255 | resolved | grade 3 |
Severe mental retardation | pre-treatment | ongoing | not resolved | grade 3 |
Cerebral hematoma | pre-treatment | 112 | resolved | grade 2 |
Deafness (bilateral) | pre-treatment | ongoing | not resolved | grade 2 |
Psychomotor retardation | pre-treatment | ongoing | not resolved | grade 2 |
Psychomotor retardation | pre-treatment | ongoing | not resolved | grade 2 |
Abnormal brain MRI | pre-treatment | 1,122 | resolved | grade 1 |
Abnormal brain MRI | pre-treatment | ongoing | not resolved | grade 1 |
Abnormal brain scan | pre-treatment | ongoing | not resolved | grade 1 |
Abnormal VEP | pre-treatment | 381 | resolved | grade 1 |
Arnold-Chiari malformation | pre-treatment | ongoing | not resolved | grade 1 |
Attention deficit/hyperactivity disorder | pre-treatment | 1,125 | resolved | grade 1 |
Communication disorder | pre-treatment | 1,125 | resolved | grade 1 |
Demyelination | pre-treatment | 1,318 | resolved | grade 1 |
Developmental delay | pre-treatment | ongoing | not resolved | grade 1 |
Gliosis | pre-treatment | ongoing | not resolved | grade 1 |
Hypoacusia | pre-treatment | 964 | resolved | grade 1 |
Hypothalamo-pituitary disorder | pre-treatment | ongoing | not resolved | grade 1 |
Hypothalamo-pituitary disorder | pre-treatment | ongoing | not resolved | grade 1 |
Impaired psychomotor skills | pre-treatment | ongoing | not resolved | grade 1 |
Mental retardation | pre-treatment | 3003 | resolved | grade 1 |
Plagiocephaly | pre-treatment | NR | resolved | grade 1 |
Psychomotor retardation | pre-treatment | ∼2.5 years | resolved | grade 1 |
Sensorineural hypoacusia at BAER | pre-treatment | ongoing | not resolved | grade 1 |
Sleep disorder | pre-treatment | 462 | resolved | grade 1 |
Tympanic membrane disorder | pre-treatment | ongoing | not resolved | grade 1 |
VEP prolonged latency | pre-treatment | 672 | resolved | grade 1 |
Gait disturbance | treatment | 37 | resolved | grade 1 |
Middle ear inflammation | 3-month follow-up | 5 | resolved | grade 1 |
Guillain-Barré syndrome | 3-year follow-up | 4 | resolved | grade 3 |
Autism | 3-year follow-up | ongoing | not resolved | grade 2 |
Speech disorder | 3-year follow-up | ongoing | not resolved | grade 2 |
Abnormal tympanometry | 3-year follow-up | ongoing | not resolved | grade 1 |
Abnormal tympanometry | 3-year follow-up | 1,167 | resolved | grade 1 |
Cognitive disorder | 3-year follow-up | ongoing | not resolved | grade 1 |
Cognitive disorder | 3-year follow-up | ongoing | not resolved | grade 1 |
Cognitive disorder | 3-year follow-up | ongoing | not resolved | grade 1 |
Deafness | 3-year follow-up | 198 | resolved | grade 1 |
Deafness | 3-year follow-up | ongoing | not resolved | grade 1 |
Deafness (bilateral) | 3-year follow-up | ongoing | not resolved | grade 1 |
Deafness (bilateral) | 3-year follow-up | 338 | resolved | grade 1 |
Developmental delay | 3-year follow-up | 2,212 | resolved | grade 1 |
Impaired psychomotor skills | 3-year follow-up | ∼1.8 years | resolved | grade 1 |
Psychomotor hyperactivity | 3-year follow-up | ∼1.1 years | resolved | grade 1 |
Psychomotor hyperactivity | 3-year follow-up | ongoing | not resolved | grade 1 |
Tympanic membrane disorder | 3-year follow-up | ongoing | not resolved | grade 1 |
Hypoacusia | 7-year follow-up | ongoing | not resolved | grade 2 |
Abnormal tympanometry | 7-year follow-up | ongoing | not resolved | grade 1 |
Cognitive disorder | 7-year follow-up | ongoing | not resolved | grade 1 |
Areflexia | 7-year follow-up | 871 | resolved | grade 1 |
Cognitive disorder | 7-year follow-up | ongoing | not resolved | grade 1 |
Deafness | 7-year follow-up | ongoing | not resolved | grade 1 |
Disturbance in attention | 7-year follow-up | ongoing | not resolved | grade 1 |
Impaired hearing | ≥8-year follow-up | ongoing | not resolved | grade 3 |
Moderate mental retardation | ≥8-year follow-up | ongoing | not resolved | grade 3 |
Obsessive-compulsive disorder | ≥8-year follow-up | ongoing | not resolved | grade 2 |
AE, adverse event; BAER, brainstem auditory evoked response; EEG, electroencephalogram; NR, not recorded; VEP, visual evoked potential. In any given phase, only those AEs that were new or worsened after the start of a particular phase were reported.
Relevant medical conditions ongoing at screening, which are not reported as AEs, were identified via manual review and are included in this table for completeness.